Clinical Laserthermia Systems AB (publ) publishes prospectus relating to the rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, OR CANADA OR ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES BEYOND WHAT IS REQUIRED UNDER SWEDISH LAW. Today, 16 August 2022, Clinical Laserthermia Systems AB (publ), (“CLS” or the “Company”) publishes the prospectus relating to the Company’s forthcoming rights issue of units, for which the subscription period starts on Tuesday 23 August 2022 (the “Rights Issue”). The prospectus has